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Abstract 
Background: Kainic acid (KA)‑induced excitotoxicity promotes cytoplasmic calcium accumulation, oxidative stress, 
and apoptotic signaling, leading to hippocampal neuronal death. Mitochondria play a critical role in neuroinflamma‑
tion and the oxidative stress response. Mitochondrial morphology is disrupted during KA‑induced seizures; however, 
it is not clear whether mitochondrial fission or fusion factors are involved in KA‑induced neuronal death.
Results: We investigated the effect of Mdivi‑1, a chemical inhibitor of the mitochondrial fission protein Drp1, on 
mitochondrial morphology and function in KA‑injected mice. Mdivi‑1 pretreatment significantly reduced seizure 
activity and increased survival rates of KA‑treated mice. Mdivi‑1 was protective against mitochondrial morphologi‑
cal disruption, and it reduced levels of phosphorylated Drp1 (Ser616) and Parkin recruitment to mitochondria. By 
contrast, levels of mitochondrial fusion factors did not change. Mdivi‑1 also reduced KA‑induced neuroinflammation 
and glial activation.
Conclusions: We conclude that inhibition of mitochondrial fission attenuates Parkin‑mediated mitochondrial degra‑
dation and protects from KA‑induced hippocampal neuronal cell death.
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Background
Kainic acid (KA) is a powerful neurotoxic analog of glu-
tamate that induces excitotoxic neuronal death in the 
hippocampus [1, 2] through the accumulation of multi-
ple cellular stress responses [3]. Mitochondria are cellular 
organelles that play a crucial role in ATP energy produc-
tion, calcium homeostasis, and inflammation in the cen-
tral nervous system. Mitochondrial dysfunction is found 
in many neurodegenerative diseases, and pathology is 
related to mitochondrial calcium overload, synaptic 
energy failure, inflammation, and oxidative stress [4, 5]. 
Mitochondrial dysfunction and structural damage have 
also been reported in epileptic seizures in humans and 
animal models [6–8].
Mitochondria are highly dynamic structures that con-
sistently change in size and shape. Mitochondrial fission 
segregates dysfunctional mitochondria for degradation, 
and fusion results in the sharing of newly synthesized 
RNA and proteins with pre-existing mitochondria to 
maintain healthy mitochondrial pools [9]. In neurons, 
mitochondrial fission facilitates movement of mito-
chondria to distal axons to supply ATP energy for 
proper synaptic function and prevents neuronal atrophy 
[10].
Balancing the processes of fission and fusion con-
trols the overall morphology and function of mito-
chondria, and numerous proteins that regulate fission 
and fusion have been reported [11]. Dynamin-related 
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protein 1 (Drp1) is a central mitochondrial fission 
protein, recruited to fission sites on the outer mito-
chondrial membrane. Loss of Drp1 has been shown 
to deplete axonal mitochondria, which is followed by 
axonal energy failure and neuronal death [12]. When 
mitochondria are damaged, their membrane potential 
is reduced and Drp1-mediated fission and apoptotic 
signals are stimulated [13]. Mitochondrial division 
inhibitor-1 (Mdivi-1) was identified during chemical 
screening for mitochondrial division inhibitors; it selec-
tively inhibits Drp1 function by inhibiting Drp1 self-
assembly [14]. Parkin, a ubiquitin-protein ligase, has 
been shown to regulate mitochondrial morphology, and 
loss-of-function Parkin mutations produce enlarged or 
swollen mitochondria with suppressed Drp1-mediated 
fission [15].
In this study, we investigated Drp1 function during KA-
induced excitotoxicity by using Mdivi-1 and suggest that 
inhibiting excessive mitochondrial fragmentation may 
have therapeutic benefit by protecting against neuronal 
death. We showed that Mdivi-1 significantly reduced sei-
zure activity and increased survival of KA-treated mice. 
By reducing Parkin-mediated mitochondrial degradation, 
Mdivi-1 may protect against mitochondrial functional 
failure and neuronal death.
Results
Mdivi‑1 reduces seizure activity and increases survival 
of mice with KA‑induced seizures
To determine whether Mdivi-1 has an effect on KA-
induced seizures and survival, we monitored seizure 
activity and survival rates for 2  h after KA injection 
(Fig.  1a, b). KA-treated (KA) mice and Mdivi-1-treated 
(KA  +  M) mice showed different distributions in the 
frequency of behavioral seizure scores after KA injec-
tion (P  <  0.05, Fig.  1a); the Chi square calculated value 
(χ2  =  106.41) was greater than the Chi square criti-
cal value (χ2* =  12.59) for P =  0.05. Mdivi-1 treatment 
reduced the frequency of seizure scores above 3 in KA-
injected mice. The frequency of seizure scores 4–6 was 
0.33 in the KA mice, whereas the frequency was 0.095 in 
the KA + M mice (P < 0.05). The mortality rate was 35 % 
(n =  7/20) in the KA mice and 12  % (n =  2/17) in the 
KA + M mice after KA injection (Fig. 1b). These results 
thus showed that Mdivi-1 reduces seizure activity and 
mortality in a mouse model of KA-induced seizures.
Mdivi‑1 attenuates neuronal cell death in the hippocampus 
after KA treatment
We subsequently used cresyl violet staining to examine 
whether Mdivi-1 protects KA mice from seizure-induced 
Fig. 1 Mdivi‑1 effects on KA‑induced seizure activity, percent survival, and neuronal cell death. The frequency of behavioral seizure scores (a) and 
percent survival (b) were monitored during the first 2 h after KA treatment (P < 0.05 KA versus KA + M). c Cresyl violet‑stained brain sections show‑
ing pyramidal neurons in the CA3 regions. The brain sections were prepared at 24 h after KA injection. Scale bar 200 µm
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neuronal death (Fig.  1c). KA mice exhibited significant 
hippocampal cell death; the thickness of pyramidal cells in 
the CA3 region was reduced, typical pyknotic nuclei were 
found, and in some cases, there was a complete loss of 
hippocampal cells (Fig. 1c, Additional file 1: Figure S1A). 
The number of NeuN-positive cells was counted in the 
CA3 regions of CTL, KA, KA  +  M, and M mice and 
KA mice showed ~60 % cell loss compared to CTL mice 
(Additional file  1: Figure  S1B). However, these changes 
were only partial or significantly reduced in the hip-
pocampus of KA + M mice. These results thereby showed 
that Mdivi-1 attenuates KA-induced neuronal cell death.
Mdivi‑1 protects mitochondrial morphology in the 
hippocampus after KA treatment
Since Mdivi-1 is a mitochondrial fission inhibitor by 
regulating Drp1, we examined whether Mdivi-1 pretreat-
ment protects neuronal death by affecting mitochondrial 
morphology in KA mice. Electron microscopy showed 
that KA induced significant changes in mitochondrial 
size and cristae structure (Fig.  2). In KA-injected mice, 
the number of mitochondria was significantly reduced 
and the area and perimeter were heterogeneous- some 
larger mitochondria had fragmented or completely 
absent cristae structure; these changes were attenuated 
by Mdivi-1 treatment (Additional file 1: Figure S2).
To examine whether Mdivi-1 pretreatment changed 
Drp1 activity, the phosphorylation of Drp1 (p-Drp1) 
at Ser616, which is known to stimulate fission after 
phosphorylation [16], was assessed by Western blot 
and immunofluorescence staining analysis (Fig.  3). The 
expression of p-Drp1 was significantly increased in KA 
mice and reduced in KA + M mice (Fig. 3a). The inten-
sity of p-Drp1 immunofluorescence staining in the hip-
pocampal CA3 region was increased (~20 %) in KA mice 
compared to CTL mice and reversed after Mdivi-1 pre-
treatment (Fig.  3b). We also found that KA increased 
the number of p-Drp1 stained GABAergic interneurons 
in the hippocampal CA3 region (Additional file  1: Fig-
ure S3) that may indicate the impaired balance between 
excitation and inhibition in CA1 neuronal circuitry [17]. 
These results thus suggest that Mdivi-1 may block p-Drp1 
mediated mitochondrial fragmentation and reduce sig-
nificant principal neuronal loss after KA and further alter 
GABAergic inhibitory interneurons.
The balance between mitochondrial fusion and fission 
is also regulated by the activity of fusion proteins. Optic 
atrophy 1 (Opa1) and mitofusin (Mfn) are localized to the 
inner and outer membranes of the mitochondria, respec-
tively, and both are required for fusion [11]. Thus, we 
examined whether the expression of Opa1 and Mfn2 was 
altered in KA mice. Western blot analysis showed that 
Opa1 and Mfn2 levels were similar among the groups of 
mice (Additional file 1: Figure S4A, B). In addition, there 
was no change in the expression of cyclophilin D (CypD), 
a matrix protein that modulates mitochondrial perme-
ability transition pore (MPTP) opening (Additional file 1: 
Figure S4C). These results thereby suggest that Mdivi-1 
regulates mitochondrial fission mainly by regulating 
Drp1 activity through reduced Ser616 phosphorylation 
to protect hippocampal neurons from KA-induced mito-
chondrial degradation and neuronal death.
Effect of Mdivi‑1 on Parkin and Hsp72 expression in the 
hippocampus after KA treatment
To examine the effect of Mdivi-1 on Parkin recruitment to 
the mitochondria of KA mice, we performed Western blot 
analysis. Parkin is normally localized in the cytoplasm and 
selectively recruited to impaired mitochondria where it 
promotes mitochondrial degradation [18]. To examine the 
subcellular localization of Parkin, cytoplasmic and mito-
chondrial fractions were isolated and Parkin levels were 
examined (Fig.  4a). Mitochondrial Parkin was induced 
by KA and significantly decreased by Mdivi-1 pretreat-
ment. Next, we examined the mitochondrial expression 
of heat shock protein 72 (Hsp72), which is a stress sensor 
that translocates to damaged mitochondria and regulates 
Parkin-mediated mitophagy [19]. Mitochondrial Hsp72 
expression was significantly induced in KA mice, and 
Mdivi-1 treatment reduced Hsp72 levels (Fig. 4b).
Effects of Mdivi‑1 treatment on hippocampal Cox‑2 
and Iba‑1 expression
To evaluate whether Mdivi-1 treatment protects the hip-
pocampus from KA-induced neuronal and glial inflam-
mation, we examined expression of Cox-2 and Iba-1 
in control (CTL), KA, and KA  +  M mice (Fig.  5). The 
expression of Cox-2 was dramatically increased in the 
hippocampal CA3 region of KA mice compared to the 
expression in CTL mice, and Mdivi-1 pretreatment 
reduced neuronal Cox-2 expression (Fig.  5a). Moreover, 
we examined microglial activation by Iba-1 expression 
in the hippocampus of CTL, KA, and KA + M mice. KA 
induced morphological changes in immune-responsive 
microglial cells and increased the number of activated 
microglial cells and the Iba-1 expression levels, which 
were significantly reduced by Mdivi-1 treatment (Fig. 5b, 
Additional file  1: Figure S5). These results suggest that 
Mdivi-1 protects the hippocampus from KA-induced 
inflammation by inhibiting mitochondrial fragmentation 
and subsequent dysfunction.
Discussion
The present study showed that Mdivi-1 pretreatment 
attenuates seizure activity and prevents KA-induced 
hippocampal cell death by reducing mitochondrial 
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morphological changes, mitochondrial fission, and Par-
kin-mediated degradation. We hypothesized that KA-
induced excitotoxicity increases mitochondrial fission, 
leading to hippocampal neuronal death. We treated mice 
with a low dose of Mdivi-1 before KA injection to exam-
ine whether Mdivi-1 exhibited neuroprotective effects by 
modifying the mitochondrial stress response at an early 
stage of seizure pathology, and we demonstrated that 
Mdivi-1 ultimately reduced neuroinflammation and neu-
ronal death in the hippocampus of KA-injected mice.
We first showed that Mdivi-1 pretreatment reduced 
seizure behaviors and increased mouse survival rates 
upon KA injection. Neuronal death in the hippocampal 
CA3 region was also significantly reduced in Mdivi-1 
pretreated KA-injected mice. These findings are in 
agreement with previous reports demonstrating that 
Mdivi-1 protects against hippocampal neuronal death 
in pilocarpine-induced seizures in rats [20, 21]. Since 
Mdivi-1 is known to inhibit mitochondrial fission fac-
tor, Drp1, we further examined mitochondrial morphol-
ogy via electron microscopy. The mitochondrial sizes 
were heterogeneous, and the mitochondrial inner and 
outer membrane structures were severely disrupted, 
suggesting that the mitochondrial membrane potential 
and other buffering functions of the mitochondria were 
impaired. Recently, Drp1 inhibition by Mdivi-1 in trau-
matic and ischemic brain injury was shown to reduce 
morphological and functional changes in mitochondria, 
cell apoptosis, neurological deficits, and brain edema 
[14, 22].
Fig. 2 Mdivi‑1 effects on mitochondrial morphology in the mouse hippocampus 24 h after KA injection. Representative electron microscopy 
images showing mitochondrial ultrastructure in the hippocampus of CTL, KA, KA + M, and M mice. Asterisks indicate the mitochondria with dis‑
rupted cristae structures. Scale bar 1 µm
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Fig. 3 Mdivi‑1 effects on mitochondrial p‑Drp1 expression in the mouse hippocampus 24 h after KA injection. a Western blots and quantitative 
protein analysis of p‑Drp1, Drp1, and VDAC1 in the hippocampal mitochondrial fractions from CTL, KA, and KA + M mice. Densitometry values were 
normalized to Drp1 and expressed as arbitrary units. Data are shown as mean ± SEM. *P < 0.05 versus CTL. #P < 0.05 versus KA. b Representative 
immunofluorescence images of NeuN, p‑Drp1, and overlay in the hippocampus of CTL, KA, and KA + M mice. Scale bar 100 µm
Fig. 4 Mdivi‑1 effects on mitochondrial Parkin and Hsp72 expression in the mouse hippocampus 24 h after KA injection. Western blots and quanti‑
tative protein analysis of Parkin (a) and Hsp72 (b) in the hippocampal mitochondrial fractions from CTL, KA, and KA + M mice. Densitometry values 
were normalized to VDAC1 and expressed as arbitrary units. Data are shown as mean ± SEM. *P < 0.05 versus CTL. #P < 0.05 versus KA
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Here, we did not examine the chronic effect of Mdivi-1 
at the time longer than 24  h after KA injection. The 
chronic changes include limbic sclerosis, a massive neu-
rodegeneration and spontaneous recurrent seizure that 
are frequently shown in the developed epilepsy such as 
human temporal lobe epilepsy (TLE). These changes are 
often studied at 7–8  weeks after status epilepticus (SE) 
induction (KA injection in our model) [23], in that we 
may study the neuroprotective effect of Mdivi-1 from 
KA-induced chronic changes. In addition, we showed 
only mitochondrial morphological changes by EM 
analysis; however, we expect significant mitochondrial 
functional changes that can be accessed by a variety of 
experimental technologies which were limited in the cur-
rent study. Future study to understand mitochondrial 
functional outcomes of the Mdivi-1 treatment would 
examine the changes in mitochondrial membrane poten-
tial, oxidative stress, calcium levels, ATP production, and 
oxidative phosphorylation.
Mitochondrial fission is controlled in part by the phos-
phorylation of Drp1; when phosphorylated at Ser616, 
Drp1 stimulates mitochondrial fission [16, 24]. We dem-
onstrated that p-Drp1 levels were significantly increased 
in mitochondria isolated from the hippocampus of KA-
injected mice and in co-localized CA3 neurons in KA-
injected mice, whereas Mdivi-1 pretreatment inhibited 
the increase of p-Drp1 expression. Mitochondrial fis-
sion has been previously shown to promote apoptosis by 
increasing mitochondrial outer membrane permeability, 
and Mdivi-1 was shown to block Bax/Bak-dependent 
cytochrome C release from mitochondria [14, 22]. We 
also demonstrated that Parkin recruitment to mitochon-
dria isolated from the hippocampus of KA-injected mice 
was increased, whereas Mdivi-1 inhibited this recruit-
ment. Parkin has been previously shown to be selectively 
recruited to damaged mitochondria with low membrane 
potential, and it plays a role in mediating mitochondrial 
degradation [18]. Our results suggest that Mdivi-1 pre-
vents mitochondrial fission and Parkin-mediated degra-
dation in KA-injected mice.
Hsp72 is a critical regulator of stress-induced Par-
kin-mediated mitochondrial degradation, since Hsp72 
Fig. 5 Mdivi‑1 effects on Cox‑2 and Iba‑1 expression in the mouse hippocampus 24 h after KA injection. Immunohistochemistry of Cox‑2 (a) and 
Iba‑1 (b) in the hippocampus of CTL, KA, KA + M, and M mice. The CA3 regions are indicated as dotted squares and shown magnified at the right. 
Scale bar 200 µm
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rapidly translocates to depolarized mitochondria prior to 
Parkin recruitment. Furthermore, impaired Parkin action 
in Hsp72 knockout mice has been associated with altered 
mitochondrial morphology and reduced mitochondrial 
function, suggesting that Hsp72 may regulate mitochon-
drial quality control and have therapeutic benefit [19]. In 
our study, we showed that Mdivi-1 inhibited the increase 
of Hsp72 expression in mitochondria isolated from the 
hippocampus of KA-induced seizure mice, suggesting 
that Mdivi-1 prevents Parkin-mediated mitochondrial 
degradation.
Based on our findings, we suggest that inhibition of 
excessive mitochondrial fission induced by KA injection 
may reduce the initial mitochondrial excitotoxic damage 
response and subsequent hippocampal neuronal death. 
Our study was limited to examine the protein expression 
or mitochondrial changes at 24 h after KA injection and 
no data were provided on early time points when we may 
show the causal effect of initial mitochondrial changes on 
KA excitotoxcitiy following neuronal death in the hip-
pocampus. We also examined changes in expression of 
Opa1 and Mfn2, two mitochondrial proteins involved in 
the regulation of mitochondrial fusion, and CypD, which 
modulates opening of MPTP [25, 26]. We observed no 
changes in expression levels for any of these proteins 
upon KA injection or Mdivi-1 pretreatment. Thus, we 
assume that the dose of Mdivi-1 administered to KA 
mice in the present study affected mitochondrial fission 
through Drp1 and Parkin-mediated mitophagy, but not 
through other mitochondrial regulatory factors in at least 
the time points we examined.
In a recent study, Mdivi-1 showed a neuroprotec-
tive effect in a mouse model of traumatic brain injury 
(TBI), where Mdivi-1 alleviated TBI-induced behavio-
ral deficits and brain edema, and neuronal death. The 
underlying mechanism may be associated with reducing 
mitochondrial morphological changes, inhibiting mito-
chondrial fission, cytochrome c release and caspase-3 
activation [27]. In addition, stimulating mitochondrial 
biogenesis by peroxisome proliferator-activated receptor 
gamma coactivator-1α (PGC-1α) was shown to be neu-
roprotective in KA-induced neuronal death by increasing 
anti-apoptotic protein and mitochondrial number and 
function of oxidative phosphorylation [28]. These stud-
ies support that normalizing mitochondrial morphology 
and the number, and enhancing mitochondrial func-
tion by Mdivi-1 are beneficial against neurodegenerative 
diseases.
During the study, we found that KA induced p-Drp1 
expression in GABAergic inhibitory neurons and Mdivi-1 
treatment reduced the level. We suggest that the p-Drp1-
mediated mitochondrial dysfunction may alter inhibitory 
GABAergic neural transmission in KA mice and lead to 
chronic seizures by disrupting the balance between exci-
tation and inhibition in CA1 neuronal circuitry [17], 
which may be attenuated by Mdivi-1 treatment.
Conclusions
In the current study, we demonstrate the neuroprotective 
effect of Mdivi-1, which supports the suggestion that cor-
recting mitochondrial morphology may reduce the extent 
of neuroinflammation and neuronal death induced by 
seizures. The molecular mechanism of Mdivi-1 involves 
attenuating mitochondrial fission through Drp1 and 
Hsp72/Parkin-mediated mitochondrial degradation. 
Mdivi-1 is a promising target for the treatment of sei-
zures, strokes, other neurotoxic and/or ischemic damage, 
as well as neurodegenerative diseases.
Methods
Animals
Male ICR mice (4-weeks old) were purchased from 
KOATECH Co. (Pyeongtaek, South Korea) and main-
tained in the animal facility at Gyeongsang National Uni-
versity (GNU). All animal experiments were approved by 
the Institutional Board of Animal Research at GNU and 
performed in accordance with the National Institutes 
of Health guidelines for laboratory animal care (GNU-
140922-M0046). Mice were individually housed with 
exposure to an alternating 12-h light/dark cycle and were 
provided with water and standard chow ad libitum.
Drug treatment and seizure induction
The mice were divided randomly into four groups: saline-
injected mice (CTL, n  =  14), KA (Abcam, Cambridge, 
MA, USA)-injected mice (KA, n  =  20), mice injected 
with Mdivi-1 (Sigma-Aldrich, St. Louis, MO, USA) and 
KA (KA + M, n = 17), and mice injected with Mdivi-1 
and saline (M, n  =  8). The KA  +  M mice received an 
intraperitoneal (i.p.) injection of 20 mg/kg Mdivi-1 emul-
sified in dimethyl sulfoxide (DMSO) twice, at 24  h and 
30  min before the injection of KA [22, 29]. Mice were 
then given an i.p. injection of 30 mg/kg KA emulsified in 
0.9 % normal saline. Control mice received i.p. injections 
of DMSO or saline at the same time. After KA injection, 
the mice were monitored for 2 h for the onset and extent 
of seizure activity. Seizure activity was quantitated using 
a six-point seizure scale, as previously described [30]. 
Only those mice that developed seizures after KA were 
used for further examination. Once a seizure was con-
firmed, the mice in each group were sacrificed at 24  h 
after KA treatment.
Tissue preparation and cresyl violet staining
Mice (CTL, n  =  5; M, n  =  3; KA, n  =  5; KA  +  M, 
n =  5) were anesthetized with zoletil (5  mg/kg; Virbac 
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Laboratories, Carros, France), perfused transcardi-
ally with heparinized saline, and their brains were fixed 
using 4 % paraformaldehyde (PFA) in 0.1 M phosphate-
buffered saline (PBS). For regular immunostaining, the 
brains were post-fixed for 6  h in 4  % PFA fixative and 
then sequentially immersed in 0.1  M  PBS containing 
15  % sucrose and PBS containing 30  % sucrose at 4  °C 
until the tissues sank to the bottom of the container. 
After being frozen in OCT compound (Sakura Finetek 
USA Inc., Torrance, CA, USA), the brains were cut into 
40-µm thick coronal sections. The sections were stained 
with cresyl violet, and visualized with a BX51 micro-
scope (Olympus, Tokyo, Japan). Digital images were 
captured.
Electron microscopy
The mice (n  =  2 each group) were anesthetized, per-
fused with saline, and fixed using 4  % PFA in 0.1  M 
phosphate buffer (PB). The brains were sectioned into 
1-mm thick slices, then stored in a mixture of 2.5 % glu-
taraldehyde in 0.1 M PB at 4 °C before further process-
ing, as previously described [31]. Images were obtained 
by a transmission electron microscope (Carl Zeiss, 
LIBRA 120, Oberkochen, Germany) at 120  kV. The 
morphological properties of mitochondria (area and 
perimeter) were quantified by using Image J (National 
Institutes of Health, Bethesda, MD, USA, http://imageJ.
nih.gov/ij).
Immunohistochemistry
Frozen free-floating brain sections were incubated with 
primary antibodies (Cox-2 from Cayman 160126 and 
Iba-1 from Wako 019-19741) overnight at 4  °C. After 
washing three times with 0.1 M PBS, the sections were 
incubated for 1 h at room temperature with biotinylated 
secondary antibodies. After washing three times with 
0.1 M PBS, the sections were incubated in avidin–bio-
tin-peroxidase complex solution (ABC solution; Vec-
tor Laboratories, Burlingame, CA, USA). The sections 
were then developed using a DAB (3,3′-diaminoben-
zidine) Peroxidase Substrate Kit (Vector Laboratories, 
Inc., Burlingame, CA, USA), mounted on gelatin-coated 
slides, warm-dried, dehydrated using a gradient of alco-
hol solutions, cleared in xylene, and mounted on cov-
erslips with Permount (Sigma-Aldrich). The sections 
were visualized with a BX51 microscope (Olympus) 
and digital images were captured. The intensity of ba-1 
expression was quantified by using Image J (NIH) and 
the number of activated microglial cells that showed 
morphological changes (long branched processes and 
increased cell body) in the CA3 regions was counted in 
4–5 fields per single slice (at the same level) from each 
group.
Immunofluorescence
For double immunostaining, free-floating sections were 
incubated with primary antibodies (NeuN from Millipore 
MAB377, p-Drp1(Ser616) from Cell Signaling #3455, and 
GABA Rα1 from Santa Cruz: sc-31405) overnight at 4 °C. 
After washing three times with 0.1 M PBS, the sections 
were incubated with Alexa Fluor488- and/or 594-conju-
gated secondary antibodies (Invitrogen Life Technolo-
gies, Carlsbad, CA, USA). Fluorescence was visualized 
with a BX51 microscope (Olympus) and Metamorph 
image analysis (Molecular Devices, Sunnyvale, CA, 
USA) was used. The number of NeuN-positive cells was 
counted from 3 fields per single slice (at the same level) 
in the CA3 regions of both hippocampi from each group.
Mitochondrial isolation and Western blot analyses
The mice were anesthetized and their brains (CTL, 
n = 7; M, n = 3; KA, n = 6, KA + M; n = 8) were quickly 
removed from the skull and both hippocampi were dis-
sected and frozen. For mitochondrial isolation, the frozen 
hippocampi were transferred to a microcentrifuge tube 
containing 200 µL of mitochondria buffer (MB: sucrose 
250 mM, KCl 10 mM, MgCl2 5 mM, ethylenediaminetet-
raacetic acid (EDTA) 1 mM, ethylene glycol tetraacetic 
acid (EGTA) 1 mM, HEPES 20 mM) with protease inhibi-
tors (Sigma-Aldrich). Tissues were homogenized and 
centrifuged at 500×g at 4  °C for 5  min, and the super-
natant was transferred to a clean tube. To separate cyto-
solic and mitochondrial fractions, the supernatant was 
centrifuged at 10,000×g at 4 °C for 5 min, and the mito-
chondrial pellet was washed and resuspended in MB. 
The protein concentration was quantified with the Bio-
Rad protein assay kit (Bio-Rad, Hercules, CA, USA), and 
samples were stored at −80  °C. Proteins were separated 
via sodium dodecyl sulphate polyacrylamide gel electro-
phoresis (SDS-PAGE), followed by electrophoretic trans-
fer onto a polyvinylidene difluoride membrane (PVDF) 
(Millipore, Billerica, MA, USA). Proteins were sub-
jected to immunoblotting with the primary antibodies 
(p-Drp1(Ser616) from Cell Signaling #3455, Parkin from 
Abcam 15954, Hsp72 from Enzo ADI-SPA-812, Opa1 
from BD 612606, Mfn2 from Abcam 56889, CypD from 
Thermo Scientific PA3-022, voltage-dependent anion 
channel 1 (VDAC1) from Abcam 15895, and β-actin 
from Sigma-Aldrich A5441) and visualized with ECL 
substrates (Pierce, Rockford, IL, USA). The Multi Gauge 
V 3.0 image analysis program (Fujifilm, Tokyo, Japan) was 
used to measure the densitometry of protein bands.
Statistical analyses
Statistical differences among groups of mice treated with 
different types of substances (vehicle, KA, and Mdivi-
1) were determined using one-way analysis of variance 
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(ANOVA), followed by Bonferroni post hoc analysis. Stu-
dent’s t test was used when only two groups were com-
pared. For comparison of seizure score data between KA 
and KA + M mice, the Chi square test was used. Statis-
tical analysis was performed using Graphpad prism 5.04 
(La Jolla, CA, USA) and dBSTAT 5.0 (Seoul, Korea). The 
experiments were repeated three times and the values are 
expressed as mean ± standard error of the mean (SEM). 
A P value <0.05 was considered statistically significant.
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